MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, Matthew R. Guthrie et al.|Cancer Cell|2017Cited by 607
Cellular immune selection with hepatitis C virus persistence in humansAndrea L. Cox, Stuart C. Ray, Timothy L. Mosbruger et al.|The Journal of Experimental Medicine|2005Cited by 304
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune MicroenvironmentGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Immunity|2018Cited by 216
Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cellsSumati Gupta, Sunil Sharma, Kelly Doyle et al.|Oncotarget|2018Cited by 27
Abstract B72: Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancerGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Cancer Immunology Research|2020Cited by 0